New diabetes clinical trial: Effects of Insulin Glargine and Lixisenatide on the Brain

Published on: March 20, 2019 at 06:00PM
Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: IGlarLixi;   Drug: Insulin Glargine 100 UNT/ML
Sponsor:   University Hospital Tuebingen
Not yet recruiting